Maha Othman: The Global Research and Mentorship Group (GRMG) is Relaunching in 2025!
Maha Othman, Editor-in-Chief at Current Opinion in Hematology, Co-Chairman SSC on Disseminated intravascular coagulopathy at ISTH shared a post on LinkedIn:
“Exciting News: The Global Research and Mentorship Group (GRMG) is relaunching in 2025!
I founded GRMG in 2020 to foster connection and collaboration during the pandemic. Honored with the 2021 Minister’s Award of Excellence; the initiative connects students and professionals in healthcare, research, and medicine with experienced mentors across the globe.
Our mission remains strong: to promote equity, build skills, and support career growth through collaborative mentorship and inclusive programming—regardless of background or location.
In 2025, GRMG will offer:
- Interactive mentorship groups
- Meet with experts
- Day-in-the-life spotlights
- Talks on scientific topics and personal development
We’d love your input! Whether you’re a student, researcher, or mentor, help shape the next chapter of GRMG by completing this short survey.
Let’s build something meaningful—together.
Questions? Contact our Program Coordinator:
George Ilbawi – [email protected].”
Find more posts featuring Maha Othman on Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD